A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis
Status:
Completed
Trial end date:
2018-07-02
Target enrollment:
Participant gender:
Summary
A Pharmacokinetic Pilot followed by a Phase I/II, Blinded, Randomized, Controlled, Parallel
Arm Trial to Evaluate the Safety, Tolerability and Efficacy of PerioSept® and Scaling and
Root Planing in Subjects with Periodontitis